NCT00293423 2021-05-13
GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma
University of California, San Francisco
Phase 1/2 Completed
Clinical Trials
4 trialsNCT04206254 2019-12-20
GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Liver Cancer
Cure&Sure Biotech Co., LTD
Phase 2/3 Unknown
NCT02122822 2017-11-17
Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96
Cure&Sure Biotech Co., LTD
Phase 1 Completed
NCT01799161 2014-11-17
Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer
University of Miami
Phase 1 Withdrawn